Last Year's Production Delays Cause Slip in Complete Genomics' Q1 Revenues | GenomeWeb

Complete Genomics recognized revenue for 900 genomes in the first quarter of 2012 for $3.9 million — a slide of 43 percent over $6.8 million in the first quarter of 2011.

The company's Q1 revenues also fell short of Wall Street's consensus estimate of $4.8 million.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.